NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas

Pancreas. 2010 Aug;39(6):735-52. doi: 10.1097/MPA.0b013e3181ebb168.

Abstract

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Neoplasms / therapy*
  • Humans
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / therapy*
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / therapy*